Researchers at Massachusetts General Hospital announced a discovery that they say creates a new roadmap for treating a rare disease. The findings were published in a peer-reviewed medical journal and have drawn attention from pharmaceutical companies.
The research team identified a molecular pathway that had previously been overlooked. They are now working to translate the lab findings into clinical trials for affected patients.